Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BBIO

Recent news which mentions BBIO

< Previous 1 2 3 4 5 6 Next >
BridgeBio Pharma Earnings Perspective: Return On Capital Employed
Tickers BBIO
Tags Earnings BZI/ROCE BBIO
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers ALLR ALRN ANPC BBIO
Tags Market News ALLR FIGS
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Tickers AGLE BBIO BCRX CRIS
Tags JAZZ BCRX Benzinga
From Benzinga
BridgeBio Shares Fall As Initial-Stage Rare Metabolic Disorder Study Kicks-off
Tickers BBIO
Tags Benzinga Health Care General
From Benzinga
BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial
Tickers BBIO
Tags Briefs Biotech General
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
Tickers BBIO BMY LEXX LIAN
Tags RSLS General TCON
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Tickers ALNY ALT APDN BBIO
Tags Market News GOVX APDN
From Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Tickers AAMC AAN AUPH AYLA
Tags Penny Stocks WIRE BBIG
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary
Tickers ABBV AGTC BBIO BIIB
Tags Biotech Catalysts / EOD Summary BBIO MNOV
From Benzinga
BridgeBio Pharma Touts Encouraging Data From Dwarfism Candidate
Tickers BBIO
Tags Movers BBIO Trading Ideas
From Benzinga
BridgeBio Pharma Posts Promising Data From Gene Therapy Trial In Ultra-Rare Disease
Tickers BBIO
Tags BBIO Movers News
From Benzinga
BridgeBio Pharma Reveals Early Positive Data For Canavan Disease
Tickers BBIO
Tags Market News Positive Clinical Data Health Care
From Benzinga
89 Biggest Movers From Friday
Tickers ADN ADXN AKRO ALLK
Tags AXLA CMRA News
From Benzinga
BridgeBio Pharma's Return On Capital Employed Insights
Tickers BBIO
Tags Market News Benzinga Earnings
From Benzinga
BridgeBio Pharma Posts Early Data From Neurological Movement Disorder Candidate
Tickers BBIO
Tags Health Care Market News News
From Benzinga
6 Analysts Have This to Say About BridgeBio Pharma
Tickers BBIO
Tags Market News Analyst Ratings Benzinga
From Benzinga
BridgeBio Partnered Protein Replacement Therapy Shows Promising Action In Painful Skin Blistering Disorder
Tickers BBIO
Tags Small Cap News BBIO
From Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Tickers BBIO BFRI BMY BTTX
Tags IBB EDIT CSLLY
From Benzinga
10 Amazing Stocks Under $10 (Part II)
Tickers ADPT BBIO DNA FUBO
Tags Market News FUBO BBIO
From Motley Fool
BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology
Tickers BBIO BMY
Tags Large Cap Benzinga Briefs
From Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Tickers ACOR ALT BBI BBIO
Tags BBI ALT Offerings
From Benzinga
Where BridgeBio Pharma Stands With Analysts
Tickers BBIO
Tags BBIO Market News Analyst Ratings
From Benzinga
BridgeBio Shares Plunge After it Details Out-Licensing Plans For 'Restructuring Initiative'
Tickers BBIO
Tags News Guidance why it's moving
From Benzinga
BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy Trial
Tickers BBIO
Tags Health Care Market News News
From Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Tickers ABBV AFIB ALDX AVDL
Tags EIGR SPPI CHGCY
From Benzinga
What 6 Analyst Ratings Have To Say About BridgeBio Pharma
Tickers BBIO
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
Where BridgeBio Pharma Stands With Analysts
Tickers BBIO
Tags BBIO Analyst Ratings Benzinga
From Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
Tickers BBIO
Tags News Phase 2 Trial Market News
From Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Tickers ACIU ADAP ALDX ALEC
Tags IMRA INAB BMY
From Benzinga
Sentynl Buys BridgeBio Pharma's Fosdenopterin Rights In Genetic Disorder
Tickers BBIO
Tags General Benzinga Briefs
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.